Trials / Not Yet Recruiting
Not Yet RecruitingNCT05863871
Real World Study of Linperlisib for Lymphoma Treatment
Real World Study of Linperlisib for Lymphoma Treatment: Multicenter, Non-interventional and Observational Real-world Study
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, non-interventional and observational real-world study to evaluate the efficacy and safety of linperlisib in patients with lymphoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Linperlisib | 80 mg, qd |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2027-06-01
- Completion
- 2027-06-01
- First posted
- 2023-05-18
- Last updated
- 2023-05-18
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05863871. Inclusion in this directory is not an endorsement.